◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
健帆生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 2.7B 1.9B 2.5B 2.7B 2.0B
Revenue Growth % 39.3% -22.8% -6.9% 37.1% --
Total Revenue 2.7B 1.9B 2.5B 2.7B 2.0B
Cost Of Revenue 515.0M 389.0M 440.0M 402.0M 288.0M
+Gross Profit 2.2B 1.5B 2.1B 2.3B 1.7B
Gross Margin % 80.8% 79.8% 82.3% 85.0% 85.2%
Total Operating Cost 1.7B 1.4B 1.6B 1.3B 960.0M
Selling Expenses 692.0M 611.0M 701.0M 598.0M 468.0M
Admin Expenses 189.0M 177.0M 138.0M 131.0M 119.0M
Rd Expenses 240.0M 245.0M 254.0M 174.0M 80.8M
Finance Expenses 32.4M -33.9M -17.8M -12.4M -27.2M
+Operating Income 1.0B 544.0M 1.0B 1.4B 1.1B
Operating Margin % 39.0% 28.3% 41.3% 53.0% 54.0%
Non Operating Income 207,100 322,300 371,600 772,700 517,700
Non Operating Expenses 38.6M 23.1M 13.0M 11.5M 22.9M
Investment Income 42.1M -- 10.5M 28.7M 15.2M
Fair Value Change Income 1.0M -- -15,000 15,000 --
Asset Disposal Income 3.6M 6.7M 864,800 982,800 --
Asset Impairment Loss 10.8M 28.2M 6.5M 56,900 38,000
Other Income 45.3M 55.3M 81.2M 52.2M 48.0M
Income Before Tax 1.0B 521.0M 1.0B 1.4B 1.0B
Income Tax 193.0M 95.3M 136.0M 211.0M 159.0M
+Net Income 814.0M 426.0M 881.0M 1.2B 873.0M
Net Margin % 30.4% 22.2% 35.4% 44.7% 44.7%
Net Income Attributable 820.0M 436.0M 890.0M 1.2B 875.0M
Minority Interest -6.0M -10.8M -8.6M -971,900 -2.2M
Eps Basic 1.05 0.55 1.12 1.49 1.10
Eps Diluted 1.07 0.57 1.13 1.49 1.08
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 1.7B 2.8B 2.6B 2.3B 1.6B
Trading Financial Assets 593.0M -- -- 150.0M --
Accounts Receivable 53.5M 74.9M 222.0M 269.0M 167.0M
Notes Receivable -- -- 17.9M 39.0M 48.4M
Notes And Accounts Receivable 53.5M 74.9M 240.0M 308.0M 216.0M
Prepayments 48.6M 11.6M 103.0M 63.1M 50.4M
Inventory 338.0M 385.0M 349.0M 197.0M 121.0M
Total Current Assets 2.8B 3.3B 3.3B 3.1B 2.0B
Fixed Assets -- 1.6B 1.2B 951.0M 643.0M
Fixed Assets Total 1.6B 1.6B 1.2B 951.0M 643.0M
Construction In Progress -- 122.0M 474.0M 301.0M 263.0M
Construction In Progress Total 244.0M 122.0M 474.0M 301.0M 263.0M
Intangible Assets 97.8M 100.0M 100.0M 101.0M 89.9M
Long Term Deferred Expenses 87.2M 94.9M 59.0M 36.0M 20.4M
Total Non Current Assets 2.6B 2.2B 2.1B 1.8B 1.2B
Total Assets 5.4B 5.5B 5.4B 4.8B 3.2B
Short Term Borrowings 77.5M 262.0M 317.0M -- --
Accounts Payable 95.3M 93.5M 102.0M 60.8M 50.2M
Advance Receipts -- -- -- -- --
Contract Liabilities 16.9M 37.6M 42.3M 20.6M 26.9M
Total Current Liabilities 767.0M 829.0M 717.0M 386.0M 331.0M
Long Term Borrowings 97.9M 405.0M -- -- --
Total Non Current Liabilities 1.3B 1.6B 1.1B 1.0B 52.2M
Total Liabilities 2.0B 2.4B 1.8B 1.4B 383.0M
Paid In Capital 799.0M 808.0M 808.0M 805.0M 799.0M
Capital Reserve 231.0M 694.0M 678.0M 618.0M 348.0M
Surplus Reserve 404.0M 404.0M 404.0M 403.0M 302.0M
Retained Earnings 2.5B 2.0B 2.1B 1.9B 1.4B
Minority Equity 758,300 5.4M 16.2M 24.8M 26.8M
Equity Attributable 3.3B 3.1B 3.6B 3.4B 2.8B
Total Equity 3.3B 3.2B 3.6B 3.4B 2.8B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 3.0B 2.4B 2.9B 2.9B 2.2B
Tax Refunds Received 1.4M 2.4M 11.6M 480,400 22.9M
Total Operating Cash Inflow 3.0B 2.5B 3.1B 3.1B 2.3B
Cash Paid For Goods 338.0M 318.0M 564.0M 470.0M 293.0M
Cash Paid To Employees 619.0M 571.0M 689.0M 491.0M 360.0M
Taxes Paid 470.0M 258.0M 453.0M 428.0M 321.0M
Total Operating Cash Outflow 2.0B 1.6B 2.2B 1.8B 1.3B
Operating Cash Flow 1.1B 917.0M 884.0M 1.2B 957.0M
Total Investing Cash Inflow 3.8B 12.6M 2.2B 4.4B 1.3B
Total Investing Cash Outflow 4.9B 262.0M 2.5B 5.1B 1.7B
Investing Cash Flow -1.1B -250.0M -306.0M -670.0M -341.0M
Cash From Borrowings 325.0M 763.0M 296.0M -- --
Dividends And Interest Paid 340.0M 562.0M 729.0M 531.0M 378.0M
Debt Repayments 651.0M 344.0M -- -- --
Total Financing Cash Inflow 419.0M 893.0M 375.0M 1.2B 73.1M
Total Financing Cash Outflow 1.4B 1.3B 741.0M 1.0B 386.0M
Financing Cash Flow -990.0M -452.0M -366.0M 165.0M -313.0M
Net Change In Cash -1.1B 215.0M 212.0M 744.0M 303.0M
Ending Cash Balance 1.7B 2.7B 2.5B 2.3B 1.6B
Capex 235.0M 247.0M 476.0M 537.0M 357.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...